After a strong finish to its fiscal year, driven by strength in international markets and continued global adoption of its flagship product, MiniMed Group Inc. (MMED) is optimistic about its long-term growth prospects.
MiniMed Group, a subsidiary of Medtronic plc (MDT), began trading on the Nasdaq Global Select Market on March 6, 2026, pricing its IPO at $20 per share.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
by Prabha Kurup
For comments and feedback: contact editorial@rttnews.com